MP3 (Microperimeter 3) Reproducibility in Healthy Subjects and Macular Patients
NCT ID: NCT02941406
Last Updated: 2016-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
22 participants
OBSERVATIONAL
2015-07-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device
NCT02445313
Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer
NCT02014389
Visual and Functional Assessment in Low Vision Patients
NCT01876147
Comparison of the Sensibility of Swept Source Optical Coherence Tomography Devices in the Detection of Neovascularisation in Large Pigment Epithelium Detachments
NCT07143526
Reading Analysis in Ophthalmologic Patients
NCT03750149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy subjects
* Men and Women aged 18 and older
* Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant
* Normal ophthalmological findings unless the investigator considers an abnormality to be clinically irrelevant
No interventions assigned to this group
Age-related macular degeneration patients
* Men and Women aged 18 and older
* Presence of a macular disease (such as dry or exudative age-related macular degeneration, diabetic maculopathy, epiretinal membrane)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
* Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant
* Normal ophthalmological findings unless the investigator considers an abnormality to be clinically irrelevant
* Men and Women aged 18 and older
* Written informed consent
* Presence of a macular disease (such as dry or exudative age-related macular degeneration, diabetic maculopathy, epiretinal membrane)
Any of the following will exclude a subject from the study:
* Any opacities (corneal scar, dense cataract) which interferes with the study relevant measurements
* Visual acuity \< 0.1 (Snellen)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vienna Institute for Research in Ocular Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prim. Prof. Dr. Oliver Findl, MBA
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Findl, MD, Prof.
Role: PRINCIPAL_INVESTIGATOR
Vienna Institute for Research in Ocular Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanusch-Krankenhaus
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MP3_REP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.